Xiangao Jiang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19 (NCT05813600) | Xiangao Jiang | 2022-08-01 |
Track Xiangao Jiang automatically
Every clearance here is in the API, with alerts when new ones post.